Sign in or register to access exclusive content on this site
REGISTER

Publication: Aromatic L-amino acid decarboxylase (AADC) deficiency: Molecular and metabolic basis and therapeutic outlook

This review article, published in the Molecular Genetics and Metabolism journal, outlines hallmark symptoms of AADC deficiency and discusses recommended diagnostic tests, current strategies for management, and potential new treatment options under investigation for AADC deficiency

  • An overview of the historical background and epidemiology of AADC deficiency and the importance of AADC in neurologic function is discussed
  • Review the wide range of clinical presentations observed and reported in the literature and understand the genetic and molecular basis of disease manifestation
  • Understand the current management of AADC deficiency including pharmacological therapies considered first-line and the outlook of a gene therapy under investigation for AADC deficiency

Himmelreich N, Montioli RM, Bertoldi M, et al. Mol Genet Metab. 2019;127(1):12–22

Once registered, you will be able to view the abstract and be provided the DOI and PubMed links for this publication.

Fast-track access

Don't have an NPI number? Switch to manual verification
MED-US-CORP-2600009 | September 2026

Register now:

This field is for validation purposes and should be left unchanged.
  • This Website is intended only for healthcare professionals (“Website“), is operated by PTC Therapeutics. (together with its affiliates “PTC”). In order to access the restricted content on this Website:
* indicates a required field
Back to NPI verification
MED-US-CORP-2600009 | September 2026
MED-US-AADC-2600006 | February 2026

Welcome to MEDhub

A website for healthcare professionals, provided by PTC Therapeutics

This educational website provides you with the latest scientific data and expert insights on the diagnosis and management of a range of rare diseases across the neuromuscular system, central nervous system, and other areas

This website may include scientific information about investigational and unlicensed products not approved for use within your country. Please refer to local regulatory guidance for country-specific information

© 2026 PTC Therapeutics. All rights reserved | MED-US-CORP-2600001 | February 2026

This content is protected.

To view it please enter your email address or NPI number below:

Register here to access the content on the site

MED-US-CORP-2600009 | September 2026

COMING SOON

The content you are trying to access is not currently available.

We will be updating the MEDhub site regularly to provide you with up-to-date, insightful expert-led content. To be notified when new additions become available, register now.